Control of 5-hydroxytryptamine release in the dorsal raphe nucleus by the noradrenergic system in rat brain. Role of α-adrenoceptors

Neuropsychopharmacology

Volumn 28, Issue 3, 2003, Pages 421-434

  Bortolozzi, A ^a   Artigas, F ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

5 hydroxytryptamine; Dorsalraphe nucleus; Frontalcortex; Habenula; Noradrenaline; adrenoceptors

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; SEROTONIN;

ANIMAL; ARTICLE; DRUG EFFECT; MALE; METABOLISM; MICRODIALYSIS; PHYSIOLOGY; RAPHE NUCLEUS; RAT; SECRETION; WISTAR RAT;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; MALE; MICRODIALYSIS; RAPHE NUCLEI; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA; SEROTONIN;

EID: 0037676185     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/sj.npp.1300061     Document Type: Article

References (82)

1. Abellan MT, Jolas T, Aghajanian GK, Artigas F (2000). Dual control of dorsal raphe serotonergic neurons by GABA(B) receptors. Electrophysiological and microdialysis studies. Synapse 36: 2134.
2. Adell A, Artigas F (1998). A microdialysis study of the in vivo release of 5-HT in the median raphe nucleus of the rat. Br J Pharmacol 125: 1361-1367.
3. Adell A, Artigas F (1999). Regulation of the release of 5-hydroxytryptamine in the median raphe nucleus of the rat by catecholaminergic afferents. Eur J Neurosci 11: 2305-2311.
4. Adell A, Sarna GS, Hutson PH, Curzon G (1989).An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats. Br J Pharmacol 97: 206-212.
5. Aghajanian GK, Wang RY (1977). Habenular and other midbrain raphe afferents demonstrated by a modified retrograde tracing technique. Brain Res 122: 229-242.
6. Alojado ME, Ohta Y, Kemmotsu O (1994). The effect of clonidine on the activity of neurons in the rat dorsal raphe nucleus in vitro.AnesthAnalg 79: 257-260.
7. Aston-Jones G, Shipley MT, Chouvet G, Ennis M, van Bockstaele E, Pieribone V et al (1991). Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology. Prog Brain Res 88: 47-75.
8. Baraban JM, Aghajanian GK (1980). Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19: 355-363.
9. Bel N, Artigas F (1996). ln vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies. J PharmacolExp Ther 278: 1064-1072.
10. 1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1: 470-480.
11. Casanovas JM, Artigas F (1996). Differential effects of ipsapirone on 5-hydroxytryptamine release in the dorsal and median raphe neuronal pathways. J Neurochem 67: 1945-1952.
12. 1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain. Br J Pharmacol 122: 733-741.
13. 1A receptors control 5-HT release in the rat medial prefrontal cortex. Neuroreport 10: 1441-1445.
14. Ceci A, Baschirotto A, Borsini F (1994). The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex. Neuropharmacology 33: 709-713.
15. Celada P, Artigas F (1993). Interaction between noradrenaline and serotonin: unchanged somatodendritic release of serotonin after noradrenergic agonist. Eur J Neurosci 6(Suppl): 168.
16. Celada P, Puig MV, Casanovas JM, Guillazo G, Artigas F (2001). Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABA(A), and glutamate receptors. J Neurosci 21: 9917-9929.
17. Dahlström A, Fuxe K (1964). Localization of monoamines in the lower brain stem. Experientia 20: 398-399.
18. Danish University Antidrepressant Group (1986). Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology 90: 131-138.
19. Danish University Antidrepressant Group (1990). Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disorder 18: 289-299.
20. Day HE, Campeau S, Watson SJ, Jr.Akil H (1997). Distribution of alpha-1A, alpha-1B and alpha-1D-adrenergic receptor mRNA in the rat brain and spinal cord. J ChemNeuroanat 13: 115-139.
21. 1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat. Neuropharmacology 33: 411-421.
22. Dresse A, Scuvee-Moreau J (1986). Influence of the alpha-2 agonist oxaminozoline (S3341) on firing rate of central noradrenergic and serotonergic neurons in the rat. Comparison with clonidine. Arch IntPhysiolBiochim 94: 99-106.
23. Garratt JC, Crespi F, Mason R, Marsden CA (1991).Effects of idazoxan on dorsal raphe 5-hydroxytryptamine neuronal function. Eur J Pharmacol 193: 87-93.
24. Gobert A, Rivet JM, Audinot V, Newman-Tancredi A, Cistarelli L, Millan MJ (1998). Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release. Neuroscience 84: 413-429.
25. 1A receptor-induced inhibition of 5-HT neuronal activity in the rat. Br J Pharmacol 126: 1741-1750.
26. Hajos M, Richards CD, Szekely AD, Sharp T (1998). An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat. Neuroscience 87: 95-108.
27. Halliday G, Harding A, Paxinos G (1995). Serotonin and tachiykinin systems. In Paxinos G (ed). The Rat Nervous System, 2nd ed. Academic Press: San Diego. pp 929-974.
28. Heal DJ, Cheetham SC (1997). SSRIs: where now, where next?In Stanford SC (ed). Selective Serotonin Reuptake Inhibitors. RG Landes Co: Austin, Texas. pp 187-218.
29. Hertel P, Nomikos GG, Svensson TH (1997). Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine. Br J Pharmacol 122: 1639-1646.
30. Hervas I, Queiroz CM, Adell A, Artigas F (2000). Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat. Br J Pharmacol 130: 160-166.
31. 1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release—I. BMY7378 and prazosin. Neuropharmacology 34: 615-620.
32. Hopwood SE, Stamford JA (2001). Noradrenergic modulation of serotonin release in rat dorsal and median raphe nuclei via alpha(1) and alpha(2A) adrenoceptors. Neuropharmacology 41: 433-442.
33. Jacobs BL, Azmitia EC (1992). Structure and function of the brain serotonin system. Physiol Rev 72: 165-229.
34. Jodo E, Chiang C, Aston-Jones G (1998). Potent excitatory influence of prefrontal cortex activity on noradrenergic locus coeruleus neurons. Neuroscience 83: 63-79.
35. Jolas T, Aghajanian GK (1997). Opioids suppress spontaneous and NMDA-induced inhibitory postsynaptic currents in the dorsal raphe nucleus of the rat in vitro. Brain Res 755: 229-245.
36. Kask A, Harro J, Tuomaine P, Rago L, Mannisto PT (1997). Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats. Naunyn Schmiedebergs Arch Pharmacol 355: 267-272.
37. L’Heureux R, Dennis T, Curet O, Scatton B (1986). Measurement of endogenous noradrenaline release in the rat cerebral cortex in vivo by transcortical dialysis: effects of drugs affecting nora-drenergic transmission. J Neurochem 46: 1794-1801.
38. Martín-Ruiz R, Puig MV, Celada P, Shapiro DA, Roth BL, Mengod G et al (2001a). Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a gluta-mate-dependent mechanism. J Neurosci 21: 9856-9866.
39. Martin-Ruiz R, Ugedo L (2001). Electrophysiological evidence for postsynaptic 5-HT(1A) receptor control of dorsal raphe 5-HT neurones. Neuropharmacology 41: 72-78.
40. Martin-Ruiz R, Ugedo L, Honrubia MA, Mengod G, Artigas F (2001b). Control of serotonergic neurons in rat brain by dopaminergic receptors outside the dorsal raphe nucleus. J Neurochem 77: 762-775.
41. Matos FF, Urban C, Yocca, FD (1996). Serotonin (5-HT) release in the dorsal raphe and ventral hippocampus: raphe control of somatodendritic and terminal 5-HT release. J Neural Transm 103: 173-190.
42. Matthews-Felton T, Linon L, Rosenblatt JS, Morrell JI (1999). First and second order maternal behavior related afferents to the lateral habenula. Neuroreport 19: 883-887.
43. McCune SK, Voigt MM, Hill JM (1993). Expression of multiple alpha adrenergic receptor subtype messenger RNAs in the adult rat brain. Neuroscience 57: 143-151.
44. Meltzer HY (1999). The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 21: S106-S115.
45. Millan MJ, Newman-Tancredi A, Audinot V, Cussac D, Lejeune F, Nicolas JP et al (2000). Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocorticalmonoaminergic transmission and depressive states. Synapse 35: 79-95.
46. Mongeau R, Blier P, de Montigny C (1997). The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Rev 23: 145-195.
47. Montgomery SA (1994). Long-term treatment of depression. Br J Psychiatry 26(Suppl): 31-36.
48. 1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors. NaunynSchmiedebergs Arch Pharmacol 358: 197-206.
49. Nicholas AP, Hokfelt T, Pieribone V (1996). The distribution and significance of CNS adrenoceptors examined with in situ hybridization. Trends PharmacolSci 17: 245-255.
50. Nicholas AP, Pieribone V, Hokfelt T (1993). Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J Comp Neurol 328: 575-594.
51. Ordway GA, Stockmeier CA, Cason GW, Klimek V (1997). Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei. J Neurosci 17: 1710-1719.
52. Pan ZZ, Grudt TJ, Williams JT (1994). Alpha 1-adrenoceptors in rat dorsal raphe neurons: regulation of two potassium con-ductances. J Physiol 478: 437-447.
53. Paxinos G, Watson C (1986). The Rat Brain in Stereotaxic Coordinates. Academic Press: Sydney.
54. Peyron C, Luppi PH, Fort P, Rampon C, Jouvet M (1996). Lower brainstem catecholamine afferents to the rat dorsal raphe nucleus. J Comp Neurol 364: 402-413.
55. Peyron C, Petit JM, Rampon C, Jouvet M, Luppi PH (1998). Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods. Neuroscience 82: 443-468.
56. Pieribone VA, Nicholas AP, Dagerlind A, Hokfelt T (1994). Distribution of alpha-1 adrenoceptors in rat brain revealed by in situ hybridization experiments utilizing subtype-specific probes. J Neurosci 14: 4252-4268.
57. Romero L, Celada P, Artigas F (1994). Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/G(o) proteins in dorsal raphe nucleus. Eur J Pharmacol 265: 103-106.
58. Rosin DL, Talley EM, Lee A, Stornetta RL, Gaylinn BD, Guyenet PG et al (1996). Distribution of alpha 2C-adrenergic receptor-like immunoreactivity in the rat central nervous system. J Comp Neurol 372: 135-165.
59. Rouquier L, Claustre Y, Benavides J (1994). Alpha 1-adrenoceptor antagonists differentially control serotonin release in the hippocampus and striatum: a microdialysis study. Eur J Pharmacol 261: 59-64.
60. Ruffolo RR, Waddell JE (1982). Receptor interactions of imidazolines. IX. Cirazolline is an alpha-1 adrenergic agonist and an alpha-2 adrenergic antagonist. J PharmacolExpTher 222: 29-36.
61. Saavedra JM, Grobecker H, Zivin J (1976). Catecholamines in the raphe nuclei of the rat. Brain Res 114: 337-345.
62. Sakai K, Crochet S (2000). Serotonergic dorsal raphe neurons cease firing by disfacilitation during paradoxical sleep. Neuroreport 11: 3237-3241.
63. Sakai K, Salvert D, Touret M, Jouvet M (1977).Afferent connections of the nucleus raphe dorsalis in the cat as visualized by the horseradish peroxidase technique. Brain Res 137: 11-35.
64. Scheinin M, Lomasney JW, Hayden-Hixson DM, Schambra UB, Caron MG, Lefkowitz RJ et al (1994). Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain. Brain Res Mol Brain Res 21: 133-149.
65. Sesack SR, Deutch AY, Roth RH, Bunney BS (1989). Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol 290: 213-242.
66. 1B agonists. Synapse 1: 3-9.
67. Steinbusch HWM (1981). Distribution of serotonin-immunoreac-tivity in the central nervous system of the rat.Cell bodies and terminals. Neuroscience 6: 557-618.
68. Stern WC, Johnson A, Bronzino JD, Morgane PJ (1981). Neurpharmacology of the afferent projections from the lateral habenula and substantianigra to the anterior raphe in the rat. Neuropharmacology 20: 979-989.
69. 2- and beta-adrenergic receptors in PCD mutantmice: a quantitative autoradiographic study. Neuroscience 94: 287-304.
70. 2A-adrenergic agonist clonidine. Brain Res 92: 291-306.
71. Takagishi M, Chiba T (1991). Efferent projections of the infralimbic (area 25) region of the medial prefrontal cortex in the rat: an anterograde tracer PHA-L study. Brain Res 566: 26-39.
72. 2A-adrenergic receptor-like immunoreactiv-ity in the rat central nervous system. J Comp Neurol 372: 111-134.
73. Tao R, Auerbach SB (1994). Anesthetics block morphine-induced increases in serotonin release in rat CNS. Synapse 18: 307-314.
74. Tao R, Hjorth S (1992). Alpha2-adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo. NaunynSchmiedebergs Arch Pharmacol 345: 137-143.
75. Tao R, Ma ZY, Auerbach SB (2000). Differential effect of local infusion of serotonin reuptake inhibitors in the raphe versus forebrain and the role of depolarization-induced release in increased extracellular serotonin. J PharmacolExpTher 294: 571-579.
76. 3H]nisoxetine: a radioligand for quantita-tion of norepinephrine uptake sites by autoradiography or by homogenate binding. J PharmacolExpTher 260: 427-436.
77. Tellez S, Colpaert F, Marien M (1999). Alpha2-adrenoceptor modulation of cortical acetylcholine release in vivo. Neuroscience 89: 1041-1050.
78. Thase ME, Entsuah AR, Rudolph RL (2001). Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 178: 234-241.
79. Unnerstall JR, Kopajtic TA, Kuhar MJ (1984). Distribution of alpha-2 agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res 319: 69-101.
80. Vandermaelen CP, Aghajanian GK (1983). Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res 289: 109-119.
81. 2C messenger RNA expression and [3H]rauwolscine binding. Neuroscience 76: 261-272.
82. 2A messenger RNA expression. Neu-roscience 76: 241-260.